CAMILA YEPES: Open Payments
NPI 1093331985 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,555 in 114 payments from 22 companies in 2025. Trend: 2023 $2,295 · 2024 $3,739 · 2025 $2,555
Food & beverage: $2,465Education: $90
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $433 |
| Janssen Biotech, Inc. | 17 | $390 |
| Botanix SB Inc | 10 | $259 |
| ABBVIE INC. | 13 | $209 |
| MAYNE PHARMA COMMERCIAL LLC | 15 | $209 |
| LNHC, Inc | 7 | $163 |
| Organon LLC | 6 | $121 |
| Amgen Inc. | 5 | $109 |
| GENZYME CORPORATION | 3 | $98 |
| Almirall LLC | 3 | $81 |
Products named: TREMFYA, SOFDRA, SKYRIZI, ZELSUVMI, DUPIXENT, OTEZLA, Klisyri, Zoryve.
Industry payments across FL — which companies pay providers there.
